Allergan, Inc. (NYSE:AGN)
CAPS Rating:
A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc.
RSS Headlines
Fool UK
Recs
Botox is huge and this stock just took its biggest dive in three years last Friday. Going to go up from here; 12-month forecast price is around $75.